2025-06-01 2026-05-31 2026-05-31 false 11355545 DAY & Night Healthcare Agency Ltd 86900Other human health activities iso4217:GBP xbrli:pure 113555452025-06-01 113555452026-05-31 113555452025-06-01 2026-05-31 11355545bus:SmallEntities2025-06-01 2026-05-31 11355545bus:AuditExempt-NoAccountantsReport2025-06-01 2026-05-31 11355545bus:AbridgedAccounts2025-06-01 2026-05-31 11355545core:WithinOneYear2026-05-31 11355545core:AfterOneYear2026-05-31 11355545core:WithinOneYear2025-06-01 2026-05-31 11355545core:AfterOneYear2025-06-01 2026-05-31 11355545core:CurrentFinancialInstruments2026-05-31 11355545core:Non-currentFinancialInstruments2026-05-31 11355545core:CurrentFinancialInstruments2025-06-01 2026-05-31 11355545core:Non-currentFinancialInstruments2025-06-01 2026-05-31 11355545core:LandBuildings2025-06-01 2026-05-31 11355545core:FurnitureFittings2025-06-01 2026-05-31 11355545core:OfficeEquipment2025-06-01 2026-05-31 11355545core:Vehicles2025-06-01 2026-05-31 11355545core:PlantMachinery2025-06-01 2026-05-31 11355545core:OtherPropertyPlantEquipment2025-06-01 2026-05-31 11355545core:LandBuildings2026-05-31 11355545core:PlantMachinery2026-05-31 11355545core:Vehicles2026-05-31 11355545core:FurnitureFittings2026-05-31 11355545core:OfficeEquipment2026-05-31 11355545core:OtherPropertyPlantEquipment2026-05-31 11355545core:Right-of-useAssets2025-06-01 2026-05-31 11355545core:Right-of-useAssets2026-05-31 11355545core:Goodwill2025-06-01 2026-05-31 11355545core:PatentsTrademarksLicencesConcessionsSimilar2025-06-01 2026-05-31 11355545core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-06-01 2026-05-31 11355545core:OtherResidualIntangibleAssets2025-06-01 2026-05-31 11355545core:Goodwill2026-05-31 11355545core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-05-31 11355545core:PatentsTrademarksLicencesConcessionsSimilar2026-05-31 11355545core:OtherResidualIntangibleAssets2026-05-31 11355545dpl:CostSales2025-06-01 2026-05-31 11355545dpl:AdministrativeExpenses2025-06-01 2026-05-31 11355545dpl:DistributionCosts2025-06-01 2026-05-3111355545core:ShareCapital2026-05-31 11355545core:SharePremium2026-05-31 11355545core:RevaluationReserve2026-05-31 11355545core:OtherReservesSubtotal2026-05-31 11355545core:ShareCapitalPreferenceShares2026-05-31 11355545core:CapitalRedemptionReserve2026-05-31 11355545core:OtherCapitalReserve2026-05-31 11355545core:RetainedEarningsAccumulatedLosses2026-05-3111355545core:ShareCapital2025-06-01 2026-05-31 11355545core:SharePremium2025-06-01 2026-05-31 11355545core:RevaluationReserve2025-06-01 2026-05-31 11355545core:OtherReservesSubtotal2025-06-01 2026-05-31 11355545core:RetainedEarningsAccumulatedLosses2025-06-01 2026-05-311135554512025-06-01 2026-05-31 1135554522025-06-01 2026-05-3111355545core:ShareCapital12025-06-01 2026-05-31 11355545core:ShareCapital22025-06-01 2026-05-3111355545core:SharePremium12025-06-01 2026-05-31 11355545core:SharePremium22025-06-01 2026-05-3111355545core:RevaluationReserve12025-06-01 2026-05-31 11355545core:RevaluationReserve22025-06-01 2026-05-3111355545core:RetainedEarningsAccumulatedLosses12025-06-01 2026-05-31 11355545core:RetainedEarningsAccumulatedLosses22025-06-01 2026-05-311135554512025-06-01 2026-05-3111355545core:Non-currentFinancialInstrumentscore:CostValuation2025-06-01 11355545core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-05-3111355545core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:CostValuation2026-05-3111355545core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-06-01 11355545core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-05-31 11355545core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-05-31 11355545core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-05-3111355545core:Non-currentFinancialInstruments2026-05-31 11355545core:Non-currentFinancialInstruments2025-05-31113555452024-06-01 113555452025-05-31 113555452024-06-01 2025-05-31 11355545core:WithinOneYear2025-05-31 11355545core:AfterOneYear2025-05-31 11355545core:CurrentFinancialInstruments2025-05-31 11355545core:Non-currentFinancialInstruments2025-05-31 11355545core:LandBuildings2025-05-31 11355545core:PlantMachinery2025-05-31 11355545core:Vehicles2025-05-31 11355545core:FurnitureFittings2025-05-31 11355545core:OfficeEquipment2025-05-31 11355545core:OtherPropertyPlantEquipment2025-05-31 11355545core:Right-of-useAssets2025-05-31 11355545core:Goodwill2025-05-31 11355545core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-05-31 11355545core:PatentsTrademarksLicencesConcessionsSimilar2025-05-31 11355545core:OtherResidualIntangibleAssets2025-05-31 11355545dpl:AdministrativeExpenses2024-06-01 2025-05-3111355545core:ShareCapital2025-05-31 11355545core:SharePremium2025-05-31 11355545core:RevaluationReserve2025-05-31 11355545core:OtherReservesSubtotal2025-05-31 11355545core:ShareCapitalPreferenceShares2025-05-31 11355545core:CapitalRedemptionReserve2025-05-31 11355545core:OtherCapitalReserve2025-05-31 11355545core:RetainedEarningsAccumulatedLosses2025-05-3111355545core:RetainedEarningsAccumulatedLosses2024-06-01 11355545core:ShareCapital2024-06-01 11355545core:SharePremium2024-06-01 11355545core:RevaluationReserve2024-06-01 11355545core:ShareCapital2024-06-01 2025-05-31 11355545core:SharePremium2024-06-01 2025-05-31 11355545core:RevaluationReserve2024-06-01 2025-05-31 11355545core:OtherReservesSubtotal2024-06-01 2025-05-31 11355545core:RetainedEarningsAccumulatedLosses2024-06-01 2025-05-311135554512024-06-01 2025-05-31 1135554522024-06-01 2025-05-3111355545core:ShareCapital12024-06-01 2025-05-31 11355545core:ShareCapital22024-06-01 2025-05-3111355545core:SharePremium12024-06-01 2025-05-31 11355545core:SharePremium22024-06-01 2025-05-3111355545core:RevaluationReserve12024-06-01 2025-05-31 11355545core:RevaluationReserve22024-06-01 2025-05-3111355545core:RetainedEarningsAccumulatedLosses12024-06-01 2025-05-31 11355545core:RetainedEarningsAccumulatedLosses22024-06-01 2025-05-3111355545bus:Director12025-06-01 2026-05-3111355545bus:PrivateLimitedCompanyLtd2025-06-01 2026-05-31
DAY & Night Healthcare Agency Ltd
Unaudited Financial Statements
for the year ended 31 May 2026
Company registration number 11355545
(England and Wales)

Company Information

For the year ended 31 May 2026
Director Hwande, Tafara

Registered office 28 Cyfarthfa Street
Cardiff
CF24 3HE

Registered number 11355545

Accountant Arthur Ellis Consultants Limited
Unit 37
Stafford Business Village
Stafford
Stafford
ST18 0TW

Statement of Financial Position

As at 31 May 2026
2026
2025
£
£
£
£
Fixed assets
Tangible assets
16,062
16,062
16,062
16,062
Current assets
Debtors
329
5,610
329
5,610
Creditors
Amounts falling due within one year
(24,270)
(1,397)
(24,270)
(1,397)
Net current assets (liabilities)
(23,941)
4,213
Total assets less current liabilities
(7,879)
20,275
Creditors
Amounts falling due after one year
296
-
296
-
Net assets (liabilities)
(7,583)
20,275
Capital and reserves
Other reserves
42,457
42,457
Profit and loss account
(50,040)
(22,182)
Total equity
(7,583)
20,275

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444 (2A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 5 October 2026 and are signed on its behalf by:

Hwande, Tafara
Hwande, Tafara
Director

Company registration number 11355545

Notes to the Financial Statements

For the year ended 31 May 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 0 (2025: 0).